Sort   by:  
 Page size 
GenomicsOverexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer
Androgen receptor (AR) is overexpressed in the majority of castration-resistant prostate cancers (CRPCs). Our goal was to study the effect of AR overexpression on the chromatin binding of the receptor and to identify AR target genes that may be important in the emergence of CRPC. We have established...
ORGANISM(S): Homo sapiens 
2013-06-27 | E-GEOD-48308 | biostudies-arrayexpress
TranscriptomicsHPCX1 linked prostate cancer
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
ORGANISM(S): Homo sapiens 
2011-12-31 | E-GEOD-24205 | biostudies-arrayexpress
TranscriptomicsmiRNA profiling of human prostate cancer cell lines treated with 5azadC and TSA to investigate epigenetic modifications
miRNA expression profiling of prostate cancer cell lines, PC-3, DU145, LAPC-4, VCaP, LNCaP, 22rv1, and normal prostate epithelial cells, PrECs, was done after treating the cells with DNA demethylating agent 5-aza-2'-deoxycytidine (5azadC; Sigma-Aldrich, St. Louis, MO) and histone deacetylase inhibit...
ORGANISM(S): Homo sapiens 
2010-01-29 | E-MEXP-2313 | biostudies-arrayexpress
TranscriptomicsMicroRNA profiling of human prostate cancer
miRNA expression profiling of 13 clinical prostate samples, 4 benign prostate hyperplasias, 5 untreated primary prostate carcinomas and 4 castration-resistant prostate cancers.
ORGANISM(S): Homo sapiens 
2010-01-31 | E-MEXP-2319 | biostudies-arrayexpress
TranscriptomicsMicroRNA profiling of human prostate cancer cell lines, xenografts and tumor samples
miRNA expression profiling in 6 prostate cancer cell lines, 9 prostate cancer xenografts, and 13 clinical prostate tumor samples
ORGANISM(S): Homo sapiens 
2007-08-03 | E-MEXP-1058 | biostudies-arrayexpress
UnknownContribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cells.
Not available
S-EPMC3197657 | biostudies-literature
UnknownMicroseminoprotein-Beta Expression in Different Stages of Prostate Cancer.
Not available
S-EPMC4777373 | biostudies-literature
UnknownDenosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial.
Not available
S-EPMC3671878 | biostudies-literature
UnknownRecurrent SKIL-activating rearrangements in ETS-negative prostate cancer.
Not available
S-EPMC4467434 | biostudies-literature
UnknownA Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer.
Not available
S-EPMC4390388 | biostudies-literature
Sort   by:  
 Page size